Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 5/20 | 0.41 |
| ▸ | RAB9A | P51151 | 5/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.39 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6519526 | 1.00 | ALDH1A1 (0.42) | ALDH1A1KMT2ANPC1RAB9AMAPT | |
| SCHEMBL6515212 | 0.88 | ALDH1A1 (0.43) | ALDH1A1KMT2ARAB9AMAPTCYP1A2 | |
| SCHEMBL6516328 | 0.87 | MEN1 (0.44) | ALDH1A1KMT2ANPC1RAB9AMAPT | |
| SCHEMBL6520666 | 0.85 | NPC1 (0.42) | ALDH1A1KMT2ANPC1RAB9AMAPT | |
| SCHEMBL6523080 | 0.85 | GAA (0.40) | KMT2ANPC1RAB9AMAPTHPGD | |
| SCHEMBL6519446 | 0.81 | LMNA (0.39) | ALDH1A1KMT2ANPC1RAB9AMAPT | |
| SCHEMBL6518785 | 0.81 | NPC1 (0.50) | ALDH1A1KMT2ANPC1RAB9AMAPT | |
| SCHEMBL6519192 | 0.79 | CYP2C19 (0.41) | ALDH1A1MAPTSMN1; SMN2HPGDCYP2C19 | |
| SCHEMBL6523837 | 0.79 | CYP2C19 (0.41) | ALDH1A1MAPTSMN1; SMN2HPGDCYP2C19 | |
| SCHEMBL6520860 | 0.79 | NAAA (0.42) | ALDH1A1KMT2ASMN1; SMN2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958366-B2 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | ALDH1A1 1254/4885KMT2A 1067/4885NPC1 3563/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.